| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8661765 | International Journal of Cardiology | 2018 | 21 Pages |
Abstract
Intravenous ferrous carboxymaltose appears to be safe in iron deficient patients with cyanosis due to CHD and/or PH, as long as care is taken to avoid air emboli. Further randomised studies are needed to confirm the safety and efficacy of intravenous iron in this setting.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Coralie Blanche, Rafael Alonso-Gonzalez, Aitor Uribarri, Aleksander Kempny, Lorna Swan, Laura Price, Stephen J. Wort, Maurice Beghetti, Konstantinos Dimopoulos,